NCT01391962 2026-02-02
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
National Institutes of Health Clinical Center (CC)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Memorial Sloan Kettering Cancer Center